David Shaw’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-201,100
| Closed | -$9.45M | – | 4916 |
|
|
2025
Q2 | $9.45M | Sell |
201,100
-1,462,383
| -88% | -$65.1M | 0.01% | 1536 |
|
|
2025
Q1 | $73.4M | Buy |
1,663,483
+1,275,750
| +329% | +$58.7M | 0.07% | 354 |
|
|
2024
Q4 | $14M | Sell |
387,733
-336,949
| -46% | -$11.8M | 0.01% | 1271 |
|
|
2024
Q3 | $23.2M | Sell |
724,682
-34,030
| -4% | -$1.27M | 0.02% | 912 |
|
|
2024
Q2 | $28.6M | Buy |
758,712
+109,865
| +17% | +$4.62M | 0.03% | 704 |
|
|
2024
Q1 | $31.9M | Buy |
648,847
+518,535
| +398% | +$24M | 0.03% | 663 |
|
|
2023
Q4 | $4.76M | Buy |
130,312
+24,576
| +23% | +$641K | ﹤0.01% | 1948 |
|
|
2023
Q3 | $2.44M | Sell |
105,736
-64,311
| -38% | -$1.76M | ﹤0.01% | 2415 |
|
|
2023
Q2 | $4.46M | Sell |
170,047
-136,498
| -45% | -$3.59M | ﹤0.01% | 1937 |
|
|
2023
Q1 | $7.89M | Buy |
306,545
+120,625
| +65% | +$3.53M | 0.01% | 1566 |
|
|
2022
Q4 | $4.84M | Buy |
185,920
+40,310
| +28% | +$993K | 0.01% | 2135 |
|
|
2022
Q3 | $4.15M | Sell |
145,610
-99,853
| -41% | -$2.86M | 0.01% | 2299 |
|
|
2022
Q2 | $6.04M | Buy |
+245,463
| New | +$8.98M | 0.01% | 1904 |
|
|
2022
Q1 | – | Sell |
-55,704
| Closed | -$3.45M | – | 5926 |
|
|
2021
Q4 | $3.45M | Sell |
55,704
-44,753
| -45% | -$2.96M | ﹤0.01% | 2797 |
|
|
2021
Q3 | $6.37M | Sell |
100,457
-25,422
| -20% | -$1.96M | 0.01% | 1887 |
|
|
2021
Q2 | $10.4M | Sell |
125,879
-24,362
| -16% | -$1.85M | 0.01% | 1464 |
|
|
2021
Q1 | $11.1M | Buy |
150,241
+82,667
| +122% | +$6.47M | 0.01% | 1287 |
|
|
2020
Q4 | $4.9M | Buy |
+67,574
| New | +$4.35M | ﹤0.01% | 1890 |
|
Other funds holding SWTX
David Shaw's SWTX Position: Q3 2025 in Review
David Shaw sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 201,100 shares — an estimated $9.45M sold.
David Shaw first reported a position in SWTX in Q4 2020 and held it in 18 quarters. The position peaked at $73.4M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- David Shaw reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- David Shaw sold 201,100 SpringWorks Therapeutics shares in Q3 2025, an estimated $9.45M.
- David Shaw first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 18 quarters.
- David Shaw's SpringWorks Therapeutics position peaked at $73.4M in Q1 2025.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.